Micron expects fiscal Q1 revenue of $61.5B ±$1.5B as it raises fiscal 2027 CapEx plans amid tighter 2027-2028 supply-demand (NASDAQ:MU)October 1, 2026
AstraZeneca, Sanofi’s RSV therapy Beyfortus for infants shows ‘protection’ in trial Finances February 21, 2023 BeritK AstraZeneca (NASDAQ:AZN) and Sanofi’s (NASDAQ:SNY) antibody remedy Beyfortus continues to indicate constant safety towards Respiratory Syncytial Virus (RSV) illness…
